Sanofi (ENXTPA:SAN) reported that its investigational therapy venglustat met all primary endpoints in a Phase 3 trial for type 3 Gaucher disease, a rare neurological condition with no approved ...

Specific tumor accumulation and attractive biodistribution highly supportive of MP0712 clinical development for treatment of DLL3-expressing cancersDosimetry data highlight Radio-DARPins as vector for ...

Thinking about starting a business in 2026? It’s a good time to get ahead of the curve. Things are changing fast, especially with technology and what people want. This article looks at some business ...